LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

Home・Listă Acțiuni・NeoGenomics Inc

NeoGenomics Inc

Deschisă

10.57 3.42

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

10.07

Maxim

10.64

Indicatori cheie
By Trading Economics
Venit	-7.2M -17M
Vânzări	-3.5M 187M
EPS	0.01
Marjă de profit	-9.164
Angajați	2,500
EBITDA	-5.8M -567K

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+56.01% upside

Dividende
By Dow Jones
Următoarele câștiguri	28 iul. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	81M 1.2B
Deschiderea anterioară	7.15
Închiderea anterioară	10.57

NeoGenomics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

28 mai 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

28 mai 2026, 16:10 UTC

Market Talk

Key BTC Level Still Seen at $80k -- Market Talk

28 mai 2026, 15:01 UTC

Market Talk

Bitcoin ETFs Speed Up Outflows -- Market Talk

28 mai 2026, 14:36 UTC

Market Talk

Bitcoin Losses Accelerate Following April PCE Report -- Market Talk

28 mai 2026, 06:54 UTC

Market Talk

Bitcoin Falls as U.S.-Iran Strikes Damp Risk Appetite -- Market Talk

28 mai 2026, 06:54 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

28 mai 2026, 06:54 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

28 mai 2026, 02:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

28 mai 2026, 02:51 UTC

Market Talk

Bitcoin Slips Amid Renewed U.S.-Iran Tensions -- Market Talk

27 mai 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

27 mai 2026, 20:08 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 mai 2026, 20:08 UTC

Market Talk

Growth Story for Hyperliquid Seen as Strong -- Market Talk

27 mai 2026, 18:04 UTC

Market Talk

Bitcoin Lower Ahead of PCE Report -- Market Talk

27 mai 2026, 17:09 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 mai 2026, 17:09 UTC

Market Talk

Mastercard Gets NY BitLicense for Stablecoin System -- Market Talk

27 mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

27 mai 2026, 16:03 UTC

Market Talk

Bitcoin Extends Loss as ETF Outflows Ramp Up -- Market Talk

27 mai 2026, 08:01 UTC

Market Talk

Bitcoin Edges Lower Amid Ongoing Geopolitical Tensions -- Market Talk

26 mai 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

26 mai 2026, 19:22 UTC

Market Talk

Cryptocurrencies Add to Losses in Afternoon Trading -- Market Talk

26 mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

26 mai 2026, 16:01 UTC

Market Talk

Bitcoin Lower as Stress Builds for Holders -- Market Talk

26 mai 2026, 15:21 UTC

Market Talk

Hyperliquid Pushes Up to New All-Time High -- Market Talk

26 mai 2026, 14:59 UTC

Market Talk

Bitcoin Rangebound, But Recent Buyers Are Underwater -- Market Talk

26 mai 2026, 14:12 UTC

Achiziții, Fuziuni, Preluări

Strategy Pauses Bitcoin Purchases to Shore Up Balance Sheet. The Stock Rises. -- Barrons.com

22 mai 2026, 18:09 UTC

Market Talk

Centralized Crypto Lending Slows in 1Q -- Market Talk

22 mai 2026, 16:54 UTC

Market Talk

Crypto Spot Volumes Fall 14% in April -- Market Talk

22 mai 2026, 14:53 UTC

Market Talk

USDT Build on Binance May Signal Refreshed Crypto Appetite -- Market Talk

22 mai 2026, 11:51 UTC

Market Talk

Bitcoin Dented by U.S. Rate-Rise Bets, Iran War Uncertainty -- Market Talk

22 mai 2026, 07:28 UTC

Market Talk

Bitcoin Falls as Investors Weigh Conflicting Iran War Headlines -- Market Talk

Comparație

Modificare preț

NeoGenomics Inc Așteptări

Obiectiv de preț

By TipRanks

56.01% sus

Prognoză pe 12 luni

Medie 14.93 USD 56.01%

Maxim 25 USD

Minim 11 USD

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruNeoGenomics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

10 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 10 analiști care au acordat evaluări ale acțiunilor NeoGenomics Inc - Dist în ultimele 3 luni.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.